Micro Computed Tomography Market Size, Share & Growth [2030]

Report Description

The global micro computed tomography market size was valued at USD 155.6 million in 2021 and is projected to reach USD 332.2 million by 2030, expanding at a CAGR of 7.11% during the forecast period, 2021–2030. The growth of the market is attributed to the increasing applications of micro-computed tomography systems.  

Get Free Sample Report

Micro computed tomography is an imaging technology similar to hospital CT scans but on a much smaller scale with far higher resolution. Micro computed tomography delivers high-resolution 3D imaging data that no other non-destructive method provides. This scanner can be used as two-dimensional monochromatic x-rays that enable high x-ray beams to flow for enhanced scanning functions. These x-rays provide a high sensitivity to tissues, lung sensitivity and high bone, and high cost-effectiveness, with a short procedure time. 

Only 3D images provide quantitative data from micro-CT scanning and 3D digital models created from virtual micro-CT slices allow researchers to assess any parameter for comparison in before-and-after studies. The benefits of micro computed tomography include its narrow bandwidth, monochromatic X-ray beams, strong bone, and lung sensitivity, good spatial resolution, cost-effectiveness, and short exposure times scans. 

The technological advancements and developments in various equipment including system design, speed, detectors, resolution, sensitivity, and computational analysis aid the biology and biomedicine sector. Micro computed tomography is used in a number of experiments, due to the necessity for non-destructive, quick, and reliable imaging methods in the life sciences and the requirement for high-resolution three-dimensional imaging for exposing the tissue organization within a complete organism tomography. 

Micro computed tomography is employed widely in many different aspects of ecology and medicine. The inherent physical constraints of each imaging technique have led to more thorough approaches by combining numerous techniques and assembling a wider variety of data ranging from cell and tissue level histomorphology to three-dimensional structures. 

The applications of three-dimensional imaging are increasing since the resolution offered is becoming better. For instance, North Star Imaging (NSI) introduced the MeVX product line in July 2021. This is a new series of high-energy X-ray systems with energies of 3,6, and 9 million electron volts (MeV). The MeVX series satisfies the criteria for higher-energy X-ray examination to pierce thick objects that are challenging to scan with conventional, lower-energy X-ray apparatus. 

This system, however, is highly dependent on sophisticated computer hardware and software, and variables such as frequent technical problems that need ongoing employee training are anticipated to limit its development. 

COVID-19 Impact 

The COVID-19 pandemic has negatively affected micro computed tomography market, as it causes a drop in the manufacture of imaging devices as well as delays in the import and export of the micro-CT machine, which is also disrupting the economy. However, since the lockdown limitations have been lifted, the market is gradually returning to normal. 

The COVID-19 pandemic has significantly impacted the tiny tomography industry as a result of a decline in imaging equipment production. The implementation of several limitations on a commercial domain, such as a limited workforce, a temporary ban on manufacturing units, and exports and imports, has hindered the micro computed tomography market.  

Market Dynamics 

The report presents a complete market overview, and market dynamics by focusing on the current market trends, existing drivers, growth opportunities, and emerging challenges that shape the outcome or overall performance of the market during the forecast period, 2022 to 2030. 

Get Free Sample Report

Major Drivers: Growing applications of micro-CT  

The research report finds that the growing product demand in research and development activities is expected to drive market expansion. According to Bruker’s BioSpinPreClinical Imaging Division, the Bruker SkyScan 1278 in vivo micro-CT system was used to support COVID-19-related research. The university’s expertise in preclinical testing is utilized to examine the effectiveness of the vaccine and medication alternatives in COVID-19 infection models. 

COVID-19 in-vivo imaging studies help researchers better comprehend how the SARS-CoV-2 virus damages the lungs. This study is expected to be one of the first COVID-19 in-vivo imaging studies using hamsters and mice. 

On the other hand, according to the International Osteoporosis Foundation (IOF) 2019, a fracture occurs every three seconds and affects one in three women and one in five men over the age of 50. This condition affects over 200 million people globally. In orthopedic surgery, a CT scan produces three-dimensional pictures of the bones that enable more precise diagnosis and treatment. A CT scan produces three-dimensional pictures of the bones that enable precise diagnosis and treatment in orthopedic surgery. The need for Micro-CT is probably going to expand as orthopedic disorders become common. 

Current Restraints: Increasing dependence on complicated computer hardware and software 

Micro computed tomography system depends heavily on sophisticated computer hardware and software, therefore issues including frequent technical problems that call for regular staff training are anticipated to limit its development. Moreover, the market for micro computed tomography is projected to be constrained by high installation and maintenance costs, a lack of experienced healthcare professionals, and a hazy reimbursement environment in developing countries.  

Market Opportunities: Initiatives are taken by the government     

Government initiatives such as healthcare funding and favorable policies, improved public awareness of early illness detection, and the rising frequency of specific diseases among individuals globally are all contributing to the micro-computed tomography market development. 

Scope of the Report

The report on the global micro computed tomography market includes an assessment of the market trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Market Segment Insights 

Life science segment to expand at a considerable CAGR

On the basis of applications, the micro computed tomography market is segmented into dentistry, plants & food, life science, and bones. The life science segment is projected to expand at a considerable CAGR during the forecast period. Life science segment is growing rapidly and constantly, owing to the rising investment in research and development. Moreover, the growth of this market is being laid by new discoveries, which help to develop smaller and larger molecular treatments as well as more effective and quicker research procedures. 

The micro-CT offers nanomechanical measurements and micro-high-resolution CT structural imaging, which is used in a variety of life science applications including animal anatomy, soft tissues, cancer, structural biology, neuroscience, cardiovascular investigations, and others.  

The dentistry segment is anticipated to account for a major market share during the forecast period, owing to its wide range of applications in dentistry. Micro computed tomography is widely used in dentistry, from dental treatment to research. The CT scanning data is used to construct a 3D digital model of the teeth. Micro-CT captures high-quality pictures of the tooth and structures surrounding it, from interior structure to outermost.

The understanding and knowledge of tooth anatomy lay the groundwork for more effective treatment strategies. Micro computed tomography imaging equipment gives the idea about the filling conditions of fillers in dental caries with nondestructive circumstances and the length of cracks in teeth. 

Get Free Sample Report

Ex vivo segment to hold a significant share of the market

Based on products, the market is bifurcated into ex-vivo and in-vivo. The ex-vivo segment accounted for a large revenue share of 76.9% in 2020. Ex vivo scanners are widely used in biomaterial studies, implants in large animals, compression studies, and material studies. It is also used in the study of excised organs such as bone, lungs, tumors, implants, and grafts. It has increasingly been used for 3D imaging of plant structures, food, and biomaterial. 

Ex-vivo refers to the experiments which take place outside an organism. Moreover, ex vivo means "out of life," which is a term used to describe items that were once alive or samples were taken from a living creature. Ex-vivo micro-CT equipment provides longer scan times (because dosage to the sample isn’t an issue), higher spatial resolution, better signal-to-noise ratios, and therefore clearer pictures. 

The in-vivo segment accounts for a significant market share. In-vivo is the scanning of live specimens. In-vivo micro-CT refers to systems that scan rats, mice, and rabbits, whereas ex-vivo micro-CT systems normally handle the remaining applications. In-vivo micro-CT system is used to study the effect of diet, body mass, medication, and therapies on bone quality, bone development, malignancies, and other regeneration models. Micro-PET or micro-SPECT scan registration has been done using in-vivo micro-CT data as a reference. 

North America is anticipated to constitute a key market share

In terms of regions, the micro computed tomography market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to constitute a key share of the market during the forecast period, owing to the presence of key market players in the region. North America dominated the micro computed tomography market with a revenue share of 31.7% in 2020. 

The high frequency of new product releases and increased funding for research activities are the major factors that are expected to drive the market expansion. Moreover, the United States has a high per capita healthcare spending, and grants from government agencies such as the National Institute of Health (NIH) to support research.  

The market in Asia Pacific is anticipated to expand at a rapid pace during the forecast period, due to the rising demand for good imaging devices. Many manufacturers are making investments in this region, for instance, DKSH Business Unit Technology and Bruker have expanded their alliance in Asia. These two companies are collaborating on the distribution of Bruker XRF devices S2 PUMA and S2 POLAR in China. DKSH will offer sales, marketing, and after-sales support for the Bruker 3D X-ray Microscopy product line as part of the expanded relationship in China. 

Get Free Sample Report